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measured and expressed numerically in relative light
units (RLUs). Results are reported by TMA data
reduction software.

Transcription Mediated Amplification for
the Diagnosis of HCV RNA
Ms Saima Javed,
Technologist, Molecular Pathology

Primer1

What is TMA?
TMA, Transcription Mediated amplification is an
isothermal (single temperature), autocatalytic (self
starting) nucleic acid target amplification system that
can produce more than a billion RNA copies of target
DNA or RNA in an hour or less.

Primer 1 binds to target
RNA.

Reversetranscriptase

RT creates cDNA
from it.
RNA:DNA duplex is
completed.
RNAse H activity of
RT degrades the
target RNA.
Primer 2 binds to
this cDNA.

How TMA Detects HCV RNA?
TMA can detect HCV RNA in human plasma and
serum. It has three main steps which are Sample
preparation, target amplification and amplicon
detection. Sample preparation involves detergent
lysis of virus followed by hybridization of free viral
nucleic acid probes oligonucleotide complimentary
to the 5' untranslated region (conserved region) of
HCV genome. An internal control is hybridized in the
same manner. The hybridized targets are then
captured on to magnetic particles which firmly hold
captured targets and allow thorough washing to
remove potential inhibitory substances.

Double stranded
DNA is generated by
RT.

Double stranded DNA template

RNA polymerase initiates
transcription of RNA from dsDNA
template

TMA starts with the addition of primers, nucleotides,
reverse transcriptase (RT) and RNA polymerase (RP).
Figure 1 depicts TMA cycle.

Primer 1 binds to cDNA and
creates dsDNA

Production of 100-1000
copies of RNA amplicon

RNAse-H activity
of RT degrades
RNA amplicon

Primer 2 binds to RNA
amplicon and creates
cDNA

RNA:DNA duplex
is completed

Figure1:
Steps Involved in Transcription Mediated Amplification
AE labelled probes

Detection of Amplified Products
Identification of amplicons is accomplished by
hybridization protection assay (HPA) and dual kinetic
assay (DKA) as explained in figure 2. In HPA single
stranded DNA probes are labelled with two different
chemiluminescent acridinium ester (AE) molecules.
One is specific for internal control RNA(IC RNA)
and another is specific for HCV amplicon. AE
molecules are chemically modified and have different
kinetics for duration of light emission. AE molecules
labelled probes bind specifically with amplicons and
are protected from hydrolysis while non-specifically
bound and unbound AE molecules are hydrolyzed
after addition of selection reagent and then auto detect
reagent is added which causes the protected AE
molecules on annealed probes to emit
chemiluminescent signals. The dual kinetic nature of
these AE molecules results in shorter “flasher signal”
and longer “glower signal”. Light emission is

RNA amplicon

AE probe binds specifically to RNA
amplicon

Unhybridised probe is hydrolyzed

Probe set 1 (Internal control)

Probe set 2 (Analyte)
Signal 1 “Flasher” for IC RNA

Signal 2 “Glower” for Analyte (HCV)

Figure 2:
Schematic Diagram of HPA and DKA
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Result Interpretation
TMA Data Reduction Software calculates two cut
offs. Analyte cut off for Analyte signal and IC cut off
for IC signal. Sample is considered negative when
analyte signal is less than the Analyte cut off
(i.e.Analyte S/CO‹1) and an IC signal is greater than
or equal to IC cut off. Sample result is considered
positive when Analyte signal is greater than or equal
to Analyte cut off (i.e. Analyte S/CO=1) and IC signal
is less than or equal to 475,000 RLUs.

Vanillyl Mandelic Acid
Dr Sahar Iqbal
Resident, Chemical Pathology
Introduction
The catecholamines (Epinephrine and norepinephrine) are secreted from the Adrenal Medulla.
Most of the catecholamines are metabolised by monoamino oxidase and chtechol-o-methyl transferase
(COMT) and produce major urinary metabolite
vanillyl mandelic acid (VMA). The others
metabolites are metanephrin and nor-metanephrin.

Advantages of TMA
! It is a single tube assay with few steps, which
makes it fast.
! TMA produces RNA amplicons which are
unstable in lab environment and are easily
inactivated by deactivation fluid.
! HPA reaction eliminates washing steps which
minimise the risk of carry over contamination.

Pheochromocytoma is the catecholamine producing
tumour of adrenal medulla, which can be diagnosed
by assessing the urinary level of VMA. In addition,
neuroblastoma, a common malignant tumour of
childhood, can also be diagnosed by urinary VMA.
About 75 per cent of the patients with neuroblastoma
show increased urinary level of VMA, however in
healthy children at least up to age of 15 years urinary
VMA and metanephrin tend to be high and variable
than adults.

Why TMA is Preferred Over PCR Based Assay?
! TMA Does Not Require Special Equipments:
TMA is isothermal; a water bath or heat block is
used instead of a thermal cycler.
! TMA is Rapid: PCR produces two copies per
cycle whereas TMA produces 100-1000 of RNA
amplicons per cycle that results in 10 billion fold
increase within about 15-30 min.
! TMA has higher sensitivity: It has potential to
detect less than 50 HCV RNA copies per ml and
residual viremia while PCR based assay has
lower detection limit of 100-1000 HCV RNA
copies per ml and is not suitable for detecting
residual viremia in HCV patient.

Significance
Urinary VMA measurements are commonly used to
screen for pheochromocytoma. It is more specific but
less sensitive than metanephrine measurement. It
helps in early diagnosis of pheochromocytoma, as
undiagnosed pheochromocytoma is a potentially
lethal condition.
Collection and Storage
Patient is instructed to collect a 24 hours urine
specimen. VMA is stable at room temperature upto
five days. Hydrochloric acid is used to preserve the
specimen for longer than five days before analysis.

Conclusion
Amplification by TMA is relatively simple, rapid and
extremely sensitive when compared with PCR. It is
FDA approved and provides good clinical
performance especially when detecting response to
therapy for viral clearance. Hence, TMA can be
incorporated in routine laboratory diagnosis of
hepatitis C virus.

Reference Range
In adults, reference value for VMA in 24 hours urine
collected specimen is approximately 7.0 mg (range
1.9 - 9.8 mg/24 hour). False positive results (more
than reference range) may be seen in the patients
taking salicylate, caffeine, phenothiazines and
antihypertensive agents. Coffee, tea, chocolate, fruit
(bananas) and vanilla containing substances should
be avoided for 72 hours prior to collection.
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blue, calcofluor, Giemsa, toluidine blue, Gomori
methenamine silver, immunofluorescent and GramWeigert. All these methods are highly efficient in the
hands of experienced microscopists.

Diagnosis of Pneumocystis jiroveci
Infections in Microbiology Laboratory
Dr Summiya Nizamuddin
Resident, Microbiology

One of the most widely used methods is
immunofluorescence using direct fluorescein
conjugated monoclonal anti Pneumocystis antibodies
which stains and fluoresces the walls of the trophic
forms and cysts, apple green. This technique is
available at the Department of Microbiology, AKUH.

Introduction
Pneumocystis jiroveci previously known as
Pneumocystis carinii is one of the most common
opportunistic pathogens in HIV infected patients.
Currently it is classified as a fungus, with a tropism
for growth on respiratory surfaces leading to
pneumonia. The organism is found in three distinct
morphological stages. The trophozoite or trophic
form, the sporozoite, and cyst, which contains
intracystic bodies also known as spores.

Other Diagnostic Modalities
Serological assays detecting Pneumocystis
antibodies and antigens have not been clinically
useful. PCR based methods, although more sensitive
are costly, labour intensive and are not widely
available.

Diagnosis
P jiroveci cannot be propagated continuously in host
cell free culture systems. Hence, its diagnosis at
present is dependent on the morphological
identification of the organisms on microscopy.
Various respiratory specimens (sputum, induced
sputum, tracheal aspirate fluid, bronchoalveolar
lavage (BAL) fluid, tissue obtained by transbronchial
biopsy, cellular material obtained by bronchial brush,
pleural fluid, and tissue obtained by open thorax lung
biopsy) could be sent to laboratory for detection.

Conclusion
Pneumocystosis should be considered in any
immunocompromised patient presenting with fever,
respiratory symptoms and an abnormal chest
radiograph. Current microscopy based methods have
produced results concordant with clinical diagnosis.
They therefore remain as a mainstay for diagnosis.

The diagnostic yield of the various specimens is
critically dependent on the underlying diseases of the
patient, the expertise of the staff evaluating the patient
and obtaining the specimen, and the expertise of the
laboratory staff for processing and examining the
specimen. Generally, the more invasive the
procedure, the better is the diagnostic yield which
ranges from 50-90 per cent for induced sputum to >90
per cent for BAL. Moreover sensitivities are also
higher in AIDS patients than in other
immunocompromised patients owing to the higher
burden of these organisms.
By use of rapid processing and staining techniques, a
laboratory diagnosis of PCP can usually be made
within a few hours.

Stain : immunofluorescence test (IFA)
Magnification: x 400
Round to oval shaped cysts and extracellular matrix
seen.
Trophozoites and sporozoites may be embedded in
extracellular matrix and fluoresce apple green.

Stains
A variety of stains have been used for the
identification of Pneumocystis. Commonly used
fungal stains are periodic acid Schiff (PAS), toluidine
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hypocalcaemia, pregnancy, nutritional and renal
o s t e o d y s t r o p h y, h y p o p a r a t h y r o i d i s m a n d
hyperparathyroidism and osteoporosis.

Laboratory Diagnosis of Metabolic Bone
Diseases
Dr Aysha Habib Khan
Assistant Professor and Consultant Chemical
Pathologist

Mild vitamin D deficiency frequently occurs in the
absence of hypocalcaemia, especially in Asians.
Secondary hyperparathyroidism may occur with
normal calcium; most of these cases are detected by
low calcium, low 25OHD levels or decreased renal
function. In patients with abnormal serum calcium or
with unusually severe bone disease, the 25-OH D and
PTH levels should always be measured. The 25 OH D
provides more useful information than the 1, 25
(OH) 2 vitamin D level.

The principal differential diagnosis in patients
presenting with bone fractures, bone pain and reduced
bone mineral density is osteoporosis versus
osteomalacia. This distinction is made from the
history, physical examination and a combination of
laboratory and radiological studies.
For an uncomplicated patient with osteomalacia and
osteoporosis, a lab workup includes serum calcium,
phosphate, creatinine, magnesium, alkaline
phosphatase, vitamin D (25OHD) Parathyroid
hormone (PHT), Thyroid stimulating hormone (TSH)
and 24-hour urine calcium. Males should have
testosterone measured.

Protein electrophoresis should be done whenever a
patient presents with new fractures. Corticosteroid
excess that causes osteoporosis can usually be
detected clinically by cushingoid features. A urine
cortisol can be helpful in puzzling cases.
Gonadal hormones are very important causes of
osteoporosis. In females who are postmenopausal, it
is not helpful to measure levels of estrogens or
gonadotropins. In males, however, testosterone levels
should be measured because there is much greater
variability in the prevalence of hypogonadism. Also,
men may have low testosterone without other clinical
symptoms. If testosterone is low, then further workup is needed.

The main purpose of laboratory tests is to check for
abnormalities of calcium/phosphate metabolism and
secondary causes of osteoporosis such as renal or
hepatic failure, acidosis and hypercalciuria.
Secondary causes of osteoporosis often go undetected
in part because of the lack of specific guidelines for
laboratory evaluation in newly diagnosed cases.
Measurement of serum total calcium and phosphate
concentrations, although readily available tests; are of
limited value in the assessment of osteoporosis.
However, low concentrations of serum phosphate and
calcium are indicative of osteomalacia. Alkaline
phosphatase is an inexpensive method of checking for
osteoblastic activity. The 24-hour urine calcium
measurement is frequently ignored but it is a valuable
and inexpensive test. High levels are seen in
idiopathic hypercalciuria, and low levels suggest
malabsorption, vitamin D deficiency, etc. The test
should be done on a patient's customary calcium
intake.

In conditions where renal wasting of phosphate is in
question, then measurement of urinary phosphate
excretion should be helpful. Phosphate excretion is
measured by calculation of the fractional excretion of
filtered phosphate from a random urine specimen by
measuring serum and urinary phosphate and serum
and urinary creatinine.
To conclude, laboratory testing plays an important
role in the early diagnosis and management of
metabolic bone diseases. It is important that
appropriate investigations are requested after
establishing a differential diagnosis. The relation of
the lab results to the disease may be complex. At
times, a close liaison between laboratory and
physician provides a better judgment.

The measurement of vitamin D is becoming
increasingly important in the management of patients
with various disorders of calcium metabolism
associated with rickets and osteomalacia, neonatal
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When a 24 hour sample is sent to the laboratory it
should be ascertained that it has been properly
collected. A preservative has been added at the
beginning of collection and the correct collection time
is used.

24 Hours Urinary Specimen Collection
Dr Ayaz Baig
Resident, Chemical Pathology
The urine specimen has been referred to as a liquid
tissue biopsy of the urinary tract that is painlessly and
easily obtained. Urine yields a great amount of
valuable information quickly and economically, but
as for all other human specimens used in laboratory,
the urine must be carefully collected, preserved, and
processed for the information to be regarded as
reliable.

Instructions for the Patients
The patient is carefully instructed about details of
collection process. The bladder is emptied at the start
of collection (e.g. in the morning at 8:00 AM) and this
time is noted on collection container. This urine is
discarded and not put into container. All subsequent
voiding are collected and put into container up to and
including urine at 8 AM the following morning. This
urine specimen will complete the 24 hours collection.

Types of Urine Collection
1. Random: these specimens usually do not require
any preservative
2. Timed specimen: usually 24 hour sample is
preferred for most of these specimens and this
requires a suitable preservative

At AKUH Clinical Laboratories
At Clinical Laboratories and all its collection centres,
patient information regarding collection of urine is
available. In addition, bottles for 24 hour urine
collection are also available at the receptions. These
bottles do not contain any preservative.

Methods for Preserving Urine Samples
Various methods of preserving urine are available,
most of which inhibit the growth of bacteria, thus
preventing many alterations from occurring. The best
method is immediate refrigeration during and after
collection. The specimen may be kept 6 to 8 hours
under refrigeration with no gross alterations and
without any preservative. There are several chemicals
available for preservation.

Genetic Analysis of Duchenne Muscular
Dystrophy
Ms Asma Hanif
Assistant Technologist, Molecular Pathology
Duchenne Muscular Dystrophy (DMD) was first
described in 1986 by Guillaume Benjamin Amand
Duchenne.

Toluene is one chemical preservative which is in
liquid form and inhibits growth of bacteria. It forms a
thin layer which covers surface of urine. It is the best
preservative as it does not interfere with various tests
done in routine urinalysis.

What is Dystrophy?
Dystrophy is basically a group of disorders that affect
body muscles. DMD occurs when a particular gene on
X chromosome fails to encode correct message for a
protein known as dystrophin. The gene is located on
Xp21 and has 79 exons spanning 2.5 megabases. It
produces mRNA of 14.6 kilobases and a protein of
over 3500 amino acid residues. Dystrophin connects
cytoskeleton of muscle fibers to the surrounding
extracellular matrix through the cell membrane.
Dystrophin associated muscular dystrophies range
from milder Becker muscular dystrophy to severe
DMD. Almost 70 per cent of the cases occur because
of inheriting a defective gene while 30 per cent result
from new mutations. Although the majority of
deletion mutations are found at 3' end, the point
mutation can occur along entire gene. Point mutations
create stop codons that produce severely reduced or
absent levels of dystrophin which links actin filaments

Thymol, a crystalline substance, inhibits the growth
of bacteria but it may interfere with protein and
bilirubin estimation.
Formalin, a liquid preservative acts by fixing the
formed elements in urine sediment, however it
interferes with reduction tests for urine sugars and
may form precipitate with urea that interfere with
microscopic examination of sediment.
Boric acid is used to preserve creatinine, uric acid and
proteins
Hydrochloric acid is used to preserve calcium,
phosphate and oxalate
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Diagnosis
DNA is isolated from peripheral blood leukocytes
using standard salting out procedure. Polymerase
chain reaction assay of dystrophin gene is carried out
using primers specific for various exons and promoter
region. PCR products are then separated on an
agarose gel containing ethidium bromide and bands
are visualised under UV light. Dystrophin gene is
amplified in 6 sets of PCR reactions. Each set includes
3-5 exons; details of exons are listed in the following
table.

to a complex of transmembrane proteins and hence to
the extracellular matrix (Figure 1).
Extracellular matrix

Dystrophin-Glycoprotein complex

Linking protein

Dystrophin
Actin binding region

á-helix

Actin filament

Figure: 1

Symptoms
The symptoms of the disease become apparent
between three to five years of age resulting in
enlargement of calf muscles, weakness of arm that
progressively loses strength in shoulders. In DMD,
creatine kinase leaks out of the muscle fibres and is
therefore found in greatly increased amounts in the
serum. In young boys with DMD, the serum
creatinine kinase level is at least five times as high as
the maximum for unaffected people and sometimes it
is 50 to 100 times as high. As the disease progresses,
failure of heart muscles and malfunction of organ
systems ultimately leads to death.

MWM

1

2

3

4

5

6

Figure 3:
Results of gel electrophoresis in a patient with DMD

Lane 1 Lane 2 Lane 3 Lane 4 Lane 5 Lane 6

Inheritance
Male offspring have a 50:50 chance of inheriting the
affected chromosome and thereby developing DMD
as it is an X-linked recessive disorder (Figure 2).
Females tend to be mildly affected compared to males
because females have a second X chromosome to
compensate for the defective gene.

45
19
51
42
46

48
17
8
44
4

Pm
43
13
47
52

3
50
6
60

49
16
32
34

PB
41
42

Figure3: Indicate deletion of exons 45 and 46 in lane
1, exon 52 in lane 3 and 34 in lane 6 or 5 thus
confirming the diagnosis of DMD.
MWM=Molecular Weight Marker 100bp.
Conclusion
Multiplex PCR is a useful assay for the diagnosis of
deletion in DMD gene, when compared with
Southern blotting it is more sensitive and rapid.
Presently, preventive measures or treatment is not
available for these disorders but molecular techniques
such as multiplex PCR can be used for their early
identification and better management.

7

Labrad

May 2007 Volume 32, Issue 2

Sample was sent for histopathology. Features were
consistent with congenital cystic adenomatoid
malformation type II (multiple small cysts < 1cm in
diameter). Child recovered well after surgery and was
discharged.

Hybrid of Cystic Adenomatoid
Malformation with Pulmonary Sequestration
Ms Fatima Mubarik, Naila Nadeem, Zishan Haider,
Gulnaz Shafqat, Shaista Afzal,
Radiology
Abstract
This is a case report of full term baby boy who was
antenatally diagnosed of having an echogenic lung
mass. The neonate under went CT scan and
consequently thoracotomy and was found to have
hybrid form of cystic adenomatoid malformation
(CCAM). The case report reminds us that cystic
adenomatoid malformation and pulmonary
sequestration are included in spectrum of
bronchopulmonary foregut malformation and if we
detect one pathology we should look for other
pathologies as these can coexist.
Introduction
CCAM and pulmonary sequestration are congenital
lesions that have distinct embryology, pathology and
natural history. Seventeen cases of intralobar
pulmonary sequestration with CCAM and 19 cases of
extra lobar pulmonary sequestration with CCAM
have been described since 1949(1).

Figure 1:
Chest X-ray Showing Increased Density with
Cystic Changes in the Left Lower Lung Zone.

Case Report
Patient was a baby boy born through emergency
lower segment caesarian section due to foetal distress
at 40th week of gestation. Birth weight of 3.3 kg,
Apgar score was 8 at 0/min, baby was tachypenic with
respiratory rate of 80/min and had sub costal
recession.
Antenatal ultrasound showed echogenic lung mass
with cystic changes in left chest, it was interpreted as
adenoid cystic malformation. On postnatal
examination, child was found to have displaced apex
beat, chest X-ray revealed air space shadowing with
cystic changes in left lower lobe with contra lateral
mediastinal shift.

Figure 2:
CT Scan Chest Lung Parenchyma Producing a Solid Density in the
Posteromedial Segment of Left Lower Lung

Enhanced CT chest confirmed X-ray findings. In
addition, an aberrant vessel from thoracic aorta
directed toward affected region was visualised. By
virtue of its position and appearance, diagnosis of
sequestered lung was suggested. On third postnatal
day, posteriolateral thoracotomy through 5th
intercostals space was carried out, intralobar
pulmonary sequestration was found in left lower lobe
with aberrant blood supply from descending thoracic
aorta.

Discussion
Pulmonary sequestration are
regions of lung
parenchyma which lack normal connection to
tracheobronchial tree and possess an anomalous
systemic blood supply usually from aorta or its major
branches (2). Its incidence is 0.15per cent -1.7per cent
in general population. It was first described by
Rokitansky and Rektorzik in 1861 (1).
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There are two types of sequestration, intralobar and
extralobar sequestration (3). CCAM is a
developmental hamartomatous abnormality of lung
with adenomatoid proliferation of cysts resembling
bronchioles (4). Chin and Tang first described CCAM
as a distinct entity in 1949 (5). CCAM represent
approximately 25 per cent of all congenital lung
lesions. CCAM communicate with bronchial tree and
derive their blood supply from pulmonary circulation.
The review of hybrid lesions by Cass et al suggested
that prognosis in hybrid CAMS appears to be more
favourable than CAM without a systemic feeding
vessel (6).

How Can We Achieve Good Response
From Trans-Arterial Chemo-Embolisation
(TACE)?
Ishtiaq Ahmed Chishty, Zishan Haider, Dawar Khan,
Tanveer ul Haq, Radiology
Viral hepatitis is becoming common in Pakistan.
Hepatoma is a lethal sequelae of chronic liver disease.
Hepatoma is among the leading causes of death
worldwide as well. The prognosis of hepatoma is grim
particularly when the tumour is unresectable or when
orthotropic liver transplantation is contraindicated.
This tumour receives most (90-100 per cent) of their
supply from hepatic artery, therefore Transarterial
Chemoembolisation (TACE) is the most common
technique used to treat unresectable HCC. TACE can
reduce viable tumour tissue and improves survival.

Intra abdominal extralobar pulmonary sequestration
/CCAM seem to have a good prognosis.
Complications such as respiratory distress, infection,
intrathoracic bleeding, haemoptysis, cardiac failure
can occur. The potential risk of malignancy
necessitates surgical excision of this congenital
pulmonary lesion (7).

Patient selection for TACE is a difficult task, because
treatment of hepatoma can be influenced by liver
function, vascular invasion, tumour size and
vascularity. Clinically, if the patient has massive
ascites and encephalopathy, the response of TACE is
poor. Inclusion and exclusion criteria for TACE are
mentioned below:

Conclusion
Ultrasonic evaluation of lung lesion done antenatally
with good postnatal imaging algorithm has a strong
impact on patient management and prognosis in
pulmonary sequestration /CCAM.
Reference
1. Madan Samuel. Management of antenatally
diagnosed pulmonary sequestration associated
with pulmonary sequestration associated with
congenital cystic adenomation malformation.
Thorax 1999;54:701-706
2. J S C Chen, N walford, Y L Yan. Fetal Intralobar
lung sequestration: Antenatal diagnosis and
management. Singapore med J 2003 vol 44(12):
630-634.
3. Mukhtar Ahmad, Volmar Jacobi, Thomas J Vogl.
Multislice CT and CT angiography for noninvasive evaluation of bronchopulmonary
sequestration. European radiology 2003
4. Caffeys pediatric Xray diagnosis 8th edition
5. Orpen N, Goodman R, Bowker C, Lakhoo K
Intralobar pulmonary sequestration with
congenital cystic adematous malformation and
rhabdomyomatous dysplasia. Pediatr Surg Int.
2003 Oct;19(8):610-1. Epub 2003 Oct 09.
6. Sakala EP, Perrott WS, Grube GL. Sonographic
characteristics of antenatally diagnosed extralobar
pulmonary sequestration and congenital cystic
adenomatoid malformation. Obstet Gynecol Surv.
1994 Sep;49(9):647-55
7. Chin KY, Tang MY. Congenital adenomatoid
malformation of one lobe of a lung with general
anasarca. Arch Pathol 1949; 48:221-9

Inclusion Criteria
! Unresectable tumors
! Patent portal vein
! Satisfactory Liver function (Normal alkaline
phosphatase and aspartate transaminase level)
! Serum bilirubin level < 2mg/dl (34 micromol/l)
! No major contraindication to angiography (e.g.
normal coagulation and renal function)
Exclusion Criteria
! Clinically apparent jaundice
! Hepatic encephalopathy
! Occluded portal vein
! Hepatofugal portal vein flow
! Extra-hepatic tumours
! Other medical conditions likely to be life
threatening within three months
! Liver rupture or tumour invasion of liver capsule
! Poor liver function
! (Coagulopathy is not correctable with Vitamin K,
Lactate dehydrogenase level >425 IU/L, elevated
alkaline phosphate level)
! Serum bilirubin level > 5mg/dL (85ìmol/l)

9

Labrad

!
!
!
!
!
!
!
!
!

May 2007 Volume 32, Issue 2

Biliary Obstruction
Serum creatinine > 2mg/dl (177µmol/l)
Haemoglobin Level < 8 g/dl (80 g/l)
White blood cell count < 2.5×103 /µl (2.5×109 /l)
Platelet count < 60×103 /µl (60×109 /l)
Pregnancy
Liver involvement > 50per cent
Albumin < 35g/L
Aspartate aminotransferase level >100 IU/L

In our institute, we are using Child-Pugh
classification for the selection of patient for TACE.
The Child-Pugh Classification system which relies on
following biochemical and clinical criteria,
a.
b.
c.
d.
e.

Figure1:
Pre-TACE contrast enhanced -CT scan shows enhancing
hepatoma in segment IV of liver

Bilirubin level
Albumin level
Prothrombin time
Degree of Ascites
Hepatic encephalopathy

These criteria have been successfully used for many
years to provide an accurate reflection of patient's
liver function. We do not perform procedure in ChildPugh Class C patients. Table 1 is showing scoring
system of Child-Pugh Classification.
Table 1: Child-Pugh Classification of Liver Function
Score
Ascites
Encephalopathy
Serum Albumin
Serum Bilirubin
PT* Prolongation

1
Absent
Absent
>3.5 g/dl
<2 mg/dl
<4 second

2
Slight to moderate
Slight to moderate
2.8-3.8 g/dl
2-3 mg/dl
4-6 second

3
Severe
Severe
<2.8 g/dl
>3 mg/dl
>6 second

Figure2:
Same patient after three sessions of TACE: Contrast enhanced -CT
scan is showing minimal residual vascularity in treated tumour

*PT=Prothrombin Time
Score of 5-6 corresponds to Child-Pugh Class A
Score of 7-9 corresponds to Child-Pugh Class B
Score of 10-15 corresponds to Child-Pugh Class C
Portal vein occlusion is not an absolute
contraindication for TACE. To achieve substantial
tumour necrosis, delaying progression to liver failure,
chemoembolisation is a well established procedure
for patients with unresectable hepatoma. TACE is an
effective way to improve survival and quality of life.
We can achieve good response from trans-arterial
chemoembolisation by proper selection of patients
(Fig 1, 2, 3).

Figure3:
Same patient after three years: There is no appreciable
tumour vascularity on contrast enhanced CT scan.
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LMWH, otherwise, falsely low values may occur.
Blood sample should be delivered to the processing
bench immediately or else falsely low values may
occur (because platelets release platelet factor 4 (PF4)
which can neutralise heparin or LMWH). For the
same reason, plasma must be separated from cells as
soon as possible, ideally within one hour of specimen
collection. Plasma can be stored for two hours at room
temperature or on ice or can be frozen.

Anti-factor Xa Assay
Natasha Ali,
Resident, Haematology
Heparin is used widely for the prevention and
treatment of thromboembolic diseases and is also
utilised during procedures of haemodialysis and
cardiopulmonary bypass surgeries. Two types of
heparin preparations widely in use today are
unfractionated heparin (UFH) and low molecular
weight heparin (LMWH). The inconvenience and
limited precision of monitoring of (UFH) therapy has
contributed to the increasing use of LMWH
preparations. The pharmacokinetic properties of
LMWH are different from (UFH) and allows for
easily monitored anticoagulant effects of a given
dose. Monitoring is, however recommended in the
following clinical settings like renal insufficiency,
obesity, paediatric patients and those on prophylactic
anticoagulant therapy in conditions like malignancy
or antiphospholipid syndrome. Anti factor Xa assay is
used to monitor LMWH therapy.

Laboratory is specifically notified as to which drug
should be measured (heparin, LMWH). Limitations
of this test include cost issues and less ready
availability than the PTT for heparin monitoring.
Reference Range for Anti-factor Xa
Patients not on anticoagulants: 0 unit/ml.
Therapeutic range for anti factor Xa for a DVT patient
differs according to the type of preparation used:
! Heparin 0.3-0.7 units/ml
! LMWH: 0.4-1.1 units/ml for twice daily
subcutaneous dosing. For once daily
subcutaneous LMWH dosing, the therapeutic
range is less certain but is approximately 1-2
units/ml.
! Target range for deep vein thrombosis (DVT)
prophylaxis (prevention): There is no defined
target range for prophylaxis of deep vein
thrombosis (DVT) because such anticoagulation
is not usually monitored. When anti-Xa levels
have been measured, mean values are usually
<0.45 units/ml.
Therapeutic range : UFH : 0.3-0.7 U/L
LMWH: 0.5-1.0 U/L
Prophylactic range: UFH : 0.1-0.29 U/L
LMWH: 0.20-0.49 U/L

Principle of anti- factor Xa is based on the fact that
both factor Xa and antithrombin III are added in
excess amounts to the test plasma and the residual
factor Xa activity is inversely proportional to the
heparin concentration. It is assumed that the patient
has a normal concentration of antithrombin III.
The test is performed by adding a known amount of
factor Xa and antithrombin to the plasma of the
patient. If heparin or LMWH is present in the patient
plasma, it will bind to antithrombin and inhibit factor
Xa. The amount of residual factor Xa is inversely
proportional to the amount of heparin in the plasma.
The amount of residual factor Xa is detected by
adding a chromogenic substrate that resembles the
natural substrate of factor Xa. Factor Xa cleaves the
chromogenic substrate, releasing a coloured
compound that can be detected by a
spectrophotometer. Results are reported as
anticoagulant concentration in anti-factor Xa
units/ml, such that high anti-factor Xa values indicate
high levels of anticoagulation. Deficiencies of
antithrombin in the patient do not affect the assay,
because excess antithrombin is provided in the
reaction.

Causes of Sub Therapeutic Antifactor Xa Level
! Specimen drawn at incorrect time (collection
times are four hours after injection of LMWH,
six hours after injection of danaparoid)
! Specimen transportation time longer than two
hours.
! Patient receiving prophylactic dose, therefore,
therapeutic range is not applicable and anti-Xa
level is actually appropriate for dose
Causes of Supra Therapeutic Antifactor Xa Level
! Renal failure (with LMWH or danaparoid)
because of decreased renal clearance.
! Heparin contamination, if specimen was drawn
from an IV heparinized line.

Specimen is collected in sodium citrate bottle (blue
top) about four hours after subcutaneous injection of
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Automated reticulocyte count like the one in manual
count is useful in differentiating anaemia caused by
marrow failure or haemolysis. Because of greater
precision, the automated reticulocyte count can help
in monitoring erythropoietin response in chronic
renal failure and marrow recovery in aplastic anaemia
or malignant disease after therapy. The immature
reticulocyte fraction is another tool of automation
with clinical significance. This may be normal in
conditions like iron deficiency and anaemia of
chronic disease, where reticulocyte response is poor.
In contrast, in conditions like aplastic anaemia, acute
myeloid leukaemia and myelodysplastic syndrome,
the IRF may be increased in spite of low or normal
reticulocyte count. Immature reticulocyte counts
have also been found to predict the optimal time for
stem cell harvesting in peripheral blood.

Automated Reticulocyte Count
Afsheen Farzand Ali,
Assistant Technologist, Haematology
Reticulocyte count is an index of erythropoietic
activity of bone marrow. Manual counting through
supra vital stain is the most common procedure of
reticulocyte counting however it is fraught with 20-25
per cent interobserver variation. Introduction of
automated technologies have greatly increased the
accuracy and precision of reticulocyte count with the
coefficient of variation (CV) of 3-12.3 per cent.
The automated technologies are based on the
principle of flowcytometry and determine the
reticulocyte count after staining with fluorescent
(thiazole orange, amamine-o, cyanene) or non
fluorescent (oxazin 750, new-methylene blue) dyes.
Briefly, residual RNA in reticulocyte is precipitated
by the dye while haemoglobin from erythrocyte is
cleared by acidic reagent leaving stained RNA. In
each sample, 32,000 red cells are counted and assayed
by volume conductivity and light scatter (VCS). The
instrument separates reticulocytes from red and white
blood cells as well as platelets. In addition, the
immature reticulocyte fraction (IRF) can also be
measured by automated instruments depending on the
intensity of RNA content, whereby mature forms
show less staining. IRF may be important from
diagnostic point of view reflecting increased
erythropoietic stimulation e.g. regeneration of
erythropoietic activity in patients receiving bone
marrow or stem cell transplantation.
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Although the reagents used for automated
reticulocyte counts seem expensive however when
we consider the cost of labour in manual counting, the
automated reticulocyte counting appears cost
effective.
The automated counting is less laborious, more
precise and accurate but it has certain limitations as
howell jolly bodies, red cell fragments, nucleated red
cells, siderotic inclusions; debris, large platelets and
platelets clumps are potential sources of error for
automated reticulocyte counting. Hb-H samples can
also give erroneously low or high results depending
on incubation time in the instruments which use new
methylene blue dye.

Figure1:
Reticulocyte count as stained by new methylene blue
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elevated AFP levels is inaccurate dating of the
pregnancy.

Triple Screen Test
Dr Beena Umar
Resident, Histopathology

Low levels of AFP and abnormal levels of hCG and
estriol may indicate that the developing baby has
Trisomy 21(Down's syndrome), Trisomy 18
(Edwards Syndrome) or another type of chromosome
abnormality.

Triple test is a maternal blood screening test that looks
for three specific substances; AFP, hCG, and Estriol.
AFP: alpha-fetoprotein is a protein that is produced
by the foetus.
hCG : human chorionic gonadotropin is a hormone
produced within the placenta
Estriol: estriol is an estrogen produced by both the
foetus and the placenta
It is a non-invasive procedure done through a blood
test with little to no known risk to the mother or
developing baby.

What Do the Triple Test Results Mean?
The triple test signifies that the mother may be at a
possible risk of carrying a baby with a genetic
disorder. It is known to have a high percentage of false
positive results. Abnormal test results warrant
additional testing for making a diagnosis like a high
resolution ultrasound and amniocentesis for
determining karyotype. If the testing still maintains
abnormal results, a more invasive procedure like
amniocentesis may be performed.

How is the Triple Screen Test Performed?
The triple screen test involves drawing blood from the
mother which takes few minutes. The blood sample is
then sent to the laboratory for testing and the results
come in few days.

2nd Biennial Conference for Chemical
Pathologist:
PSCP Collaborate with AKU

When is the Triple Screen Test Performed?
The triple screen test is performed between the 15th
and 20th week of pregnancy although results obtained
in the 16th -18th week are said to be the most accurate.

Reported by Dr Imran Siddiqui
Associate Professor, Chemical Pathology
The two-day 2nd Biennial
Conference of Pakistan
Society of Chemical
Pathologists (PSCP) opened
at Liaquat National Hospital
and PNS Shifa on March 9
and at Aga Khan University
(AKU) on March 10, 2007.
Organised by PSCP and
hosted by AKU. The
Conference also included
Chief Guest
Lt. Gen (Retd,)
two workshops. Invited
S. Azhar Ahmed
speakers from Singapore,
Islamabad and Lahore as well as from Aga Khan
University Hospital (AKUH), presented their papers
on this sub-specialty and findings from latest
research. The Conference's inaugural session was
well attended by professionals from all over Pakistan,
and was opened by Lt. Gen (Retd) S. Azhar Ahmed,
Vice Chancellor Baqai University, Karachi, who also

All pregnant women should be offered for triple
screen, but it is recommended for women who:
! have a family history of birth defects;
! are 35 years or older;
! used possible harmful medications or drugs
during pregnancy;
! have diabetes and use insulin;
! had a viral infection during pregnancy;
! have been exposed to high levels of radiation.
What Does the Triple Screen Test Look For?
The triple screen is measuring high and low levels of
AFP and abnormal levels of hCG and estriol. The
results are combined with the mother's age, weight,
ethnicity and gestation of pregnancy in order to assess
probabilities of potential genetic disorders.
High levels of AFP may suggest that the developing
baby has a neural tube defect such as spina bifida or
anencephaly. However, the most common reason for

13

Labrad

May 2007 Volume 32, Issue 2

The key features of this Conference were two
workshops namely Recent advancements in chemical
pathology and role of PCR in chemical pathology.
Seminar on infertility, plenary lecture and scientific
session including poster presentations. Joint efforts
from chemical pathologists of Ziauddin University,
Liaquat National Hospital and PNS Shifa resulted in
the success of this scientific meeting. Section of
Chemical Pathology and Conference Secretariat of
Aga Khan University led the proceedings. The
contribution and support of Dean Medical College,
Aga Khan University, Dr Mohammad Khurshid was
immense.

inaugurated a concurrent 'Scientific Poster
Exhibition' and a display of pathology-related
equipment exhibition.

Chief Guest Lt. Gen (Retd,), S. Azhar Ahmed
Chancellor Baqai University Inaugurating the Scientific Exhibition

Following a recitation from
the Quran, Dr Imran
Siddiqui, Chairman
Organising Committee,
welcomed the guests and
provided an overview of the
Conference. Brigadier
Farooq A. Khan, Deputy
Commandant, Armed Forces
Institute of Pathology and
President PSCP recognised
Dr Imran Siddiqui,
Chair Organizing Committee the efforts of PSCP and its
contribution to promote
education through such
conferences, especially
thanking the invited
international and National
speakers. The chief guest Lt.
Gen (Retd) S. Azhar Ahmed,
referred in his speech to the
importance of linkages in
healthcare, and highlighted
the significance of the
human factor-notwithstanding
technological innovations. Brig Farooq Ahmed Khan,

Dr Shirnen Mansoor, Medical Office AKHU Receive Best Poster
Presentation Award

The conference was designed to provide an
opportunity to chemical pathologists, technicians and
other members of Pakistan's medical community to
expand and build upon their knowledge and
understanding of the dynamic field, presently
undergoing very rapid change with new technology.
Available facilities in Pakistan are fast increasing and
the organisers saw the necessity of expanding the pool
of appropriately-educated chemical pathologists. It is
important that not only chemical pathologists but all
healthcare providers keep abreast of the latest trends
and technologies. This conference provided a relevant
and quality educational opportunity to the chemical
pathologists of Pakistan and continued the AKU
tradition of leadership and excellence in medical
education. This conference also received coverage in
the leading newspapers of Karachi.

President PSCP
Addressing on Occasion
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